Industry Research Reports and Market Analysis at MindBranch.com Research Index | Publishers | My Account | Contact Us | About MindBranch
Welcome Guest  (Login/Register) |  0 items
  
Advanced Search > | Tips >
Contact a
Research Assistant

US 800-774-4410
or +1-240-747-3094

Search Assistance >

Home  > Healthcare  >  Pharmaceutical  >  General Pharmaceutical

Abbott Laboratories - SWOT Analysis - SWOT Analysis


Published Date: November 2008
Published By: Datamonitor
Page Count: 34
Order Code: R313-41620
 
DescriptionTable of ContentsSimilar
Products

Datamonitor's Abbott Laboratories - SWOT Analysis company profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.

Abbott Laboratories (Abbott), one of the Big Pharma companies, is engaged in the discovery, development, manufacture, and sale of health care products including pharmaceuticals, diagnostics and nutritional products across the globe. The company operates in more than 130 countries across the globe. It is headquartered in Chicago, Illinois and employs about 68,000 people. The company recorded revenues of $25,914.2 million during the financial year (FY) ended December 2007, an increase of 15.3% over 2006. The operating profit of the company was $4,578.5 million during FY2007, as compared to an operating profit of $2,042.2 million in 2006. The net profit was $3,606.3 million in FY2007, as compared to a net profit of $1,716.7 million in 2006.

Scope of the Report
  • Provides all the crucial company information required for business and competitor intelligence needs
  • Contains a study of the major internal and external factors affecting the company in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams
  • Data is supplemented with details on the company’s history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement
Reasons to Purchase
  • Support sales activities by understanding your customers’ businesses better
  • Qualify prospective partners and suppliers
  • Keep fully up to date on your competitors’ business structure, strategy and prospects
  • Obtain the most up to date company information available

Similar Products
Kuwait Pharmaceuticals and Healthcare Report Q4 2008
Published Dec 2008 by Business Monitor International


France Pharmaceuticals and Healthcare Report Q4 2008
Published Dec 2008 by Business Monitor International


Kenya Pharmaceuticals and Healthcare Report Q4 2008
Published Dec 2008 by Business Monitor International


Bangladesh Pharmaceuticals and Healthcare Report Q4 2008
Published Dec 2008 by Business Monitor International


India Pharmaceuticals and Healthcare Report Q4 2008
Published Dec 2008 by Business Monitor International


Study for Opportunities Assessment for Hepatitis B Therapeutics in Taiwan
Published Dec 2008 by Frost & Sullivan


New Types of HIV Drugs
Published Dec 2008 by Trimark Publications


Diabetes Death Rate by Race and Sex in the U.S., 1979-2006
Published Dec 2008 by Trimark Publications


Hypertension Drugs Newly Prescribed or Continued in the U.S., 1994-2007
Published Dec 2008 by Trimark Publications


Infant Mortality Rate by Country, 2008
Published Dec 2008 by Trimark Publications




 


Privacy Policy | Terms & Conditions | Site Map | Return Policy | Help FAQs
Copyright © 1999-2008, All Rights Reserved, MindBranch.com
Trust-e Logo
Phone: 800-774-4410 (US) or +1-240-747-3094 (Int'l)
Hours: 7:00 a.m. to 7:00 p.m. EST Monday through Friday
Email: support@mindbranch.com